Genedrive Share News (GDR)

Genedrive makes progress with HCV kit in first half

(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.

BGF Investment Management Now Owns 12.8% Stake In Genedrive (ALLISS)

LONDON (Alliance News) - Genedrive PLC said Monday that BGF Investment Management Ltd now owns a 12.8% stake in the company.BGF's stake in the firm prior to Monday's deal, if any,

Genedrive To Participate In Study For Use Of HCV Assay In Pharmacies

LONDON (Alliance News) - Genedrive PLC on Thursday said it will participate in an international multicentre trial to assess the impact of out-reach HCV diagnostics and therapy in a pharmacy versus

Genedrive to participate in three-country HCV therapy study

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Thursday that it will participate in an international multicentre trial, designed to assess the impact of outreach HCV diagnostics and therapy in a pharmacy setting when compared conventional treatment pathways.

Genedrive Appoints Chris Yates As Non-Executive Director

LONDON (Alliance News) - Diagnostics company Genedrive PLC said Wednesday it appointed Chris Yates as non-executive director with immediate effect.Yates has been Chief Executive Officer of

Genedrive Partners With FIND To Evaluate Its Hepatitis C Virus Kit

LONDON (Alliance News) - Genedrive PLC said Wednesday it partnered with the Foundation for Innovation of New Diagnostics, or FIND, which will evaluate its hepatitis C virus kit.The kit is a

Genedrive Given Grant For NHS Point-Of-Care Test Development

LONDON (Alliance News) - Genedrive PLC's said Wednesday it was awarded a multi-partner grant to develop a pharmacogenetic test to fight antibiotic-related hearing loss in newborn molecular was

Genedrive To Sell Two Divisions For Up To GBP1.9 Million In Cash

LONDON (Alliance News) - Genedrive PLC said Monday it proposed the disposal of the its contract research and pharmacogenomics divisions for up to GBP1.9 million in cash to biotechnology company 2

Genedrive To Unveil Hepatitis C ID Kit In Singapore Exhibition

LONDON (Alliance News) - Molecular diagnostics firm Genedrive PLC said Tuesday it is to premiere its hepatitis C ID kit in the Asia Pacific at an in will

Genedrive Confident For Future As Interim Loss Narrows On Lower Costs

LONDON (Alliance News) - Genedrive PLC said on Tuesday that its pretax loss narrowed in the first half of the financial year as financing costs reduced for six months to the a

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 14 March PrudentialFull Year ResultsDignityFull Year MacdonaldHalf 15

Genedrive's revenues rise despite difficulties in India

(ShareCast News) - Genedrive, an AIM listed near patient molecular diagnostics diagnostics company, has progressed well in the second half despite difficulties faced with its Tuberculosis (TB) assay in India. Group revenues "significantly" rose to £2.8m for six months ended 31 December 2016, up f

Genedrive supplies field test units to US DoD

(ShareCast News) - Manchester-based diagnostics company genedrive announced on Monday that it has supplied Genedrive units and assays to the United States Department of Defense for field trials, as part its $7.8m development programme for a handheld device to allow for the detection of biohazards su

Genedrive Human Genotyping Test Gets EU Certification

Genedrive's revenue rises while it re-focuses company

(ShareCast News) - AIM-listed molecular diagnostics company Genedrive's revenue grew as it re-focused to concentrate on its Genedrive platform, launched a new test in India and changed its name. For the year ended 30 June, the company, formerly Epistem, reported 12% growth in turnover to £5.1m, comp